483
Hospira, Inc.Hospira, Inc. – FDA 483, Nov 14, 2023
Record Details
An FDA inspection of Hospira, Inc. in Rocky Mount, NC, revealed significant deficiencies in laboratory controls and product testing. The firm lacked adequate analytical methods to detect unknown impurities in drug products manufactured on shared equipment, including highly potent drugs. Additionally, Hospira failed to perform container closure integrity testing as part of its release criteria, raising concerns about product sterility and quality.
View Company Profile
ID · 5c3e063a-836d-4935-b609-0dea69d3e704
Other documents for Hospira, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.